COMMUNIQUÉS West-GlobeNewswire
-
Regeneron to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on October 31, 2024
26/09/2024 - 22:05 -
Better Choice Company to Present at the 2024 ThinkEquity Conference and Provides Detail on Sales in China and the Acquisition of SRx Health
26/09/2024 - 22:10 -
Cue Biopharma Announces Proposed Public Offering
26/09/2024 - 22:27 -
Benitec Biopharma Releases Full Year 2024 Financial Results and Provides Operational Update
26/09/2024 - 22:30 -
GRI Bio (NASDAQ: GRI) to Participate in a Virtual Investor CEO Connect Segment
25/09/2024 - 14:45 -
Kronos Bio to Present Data at ACR Convergence 2024 to Support p300 KAT Inhibition as an Approach to Anti-Inflammatory Therapy
25/09/2024 - 14:55 -
QHSLab Secures Grant Sponsorship from a Global Leader in Consumer Health to Advance Digital Medicine Tools for Allergy Management in the Primary Care Setting
25/09/2024 - 15:00 -
GoLiver Therapeutics is the winner of the France 2030 “innovation in Biotherapies and Bioproduction” call for its GOCLINICALS project, dedicated to a novel stem cell-based liver therapy
25/09/2024 - 15:00 -
SIRONA BIOCHEM Poised for Profitability in 2025 with Anti-Aging Product Rollout
25/09/2024 - 15:00 -
Sanner Group acquires Gilero to expand its global medical device offering
25/09/2024 - 15:00 -
InBrain Pharma to Present Positive Results from Its DIVE-I Phase I/II Clinical Trial for Parkinson’s Disease at the Congress of Parkinson’s Disease and Movement Disorders from September 27 to October 1 in Philadelphia
25/09/2024 - 15:00 -
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
25/09/2024 - 15:02 -
Koelis Announces New Compact 3D Probe to Improve Workflow and Reprocessing
25/09/2024 - 15:07 -
ClinicalTrials.EU platform rolled out across Europe
25/09/2024 - 15:14 -
Cyclacel Pharmaceuticals Announces Completion of Enrollment in the Biomarker-Enriched Patient Cohort of Its Phase 2 Study
25/09/2024 - 15:15 -
Dallas Business Journal Recognizes USOSM COO Alisa Ulrey for Leadership
25/09/2024 - 15:47 -
Spinogenix Announces Launch of a Phase 2 Clinical Trial Evaluating SPG302 for the Treatment of Schizophrenia
25/09/2024 - 16:00 -
Capsa Healthcare Unveils the New Tryten P-Series: Engineering a Path to Better Care
25/09/2024 - 16:12 -
LifeLabs to Honour National Day for Truth and Reconciliation with Educational Initiatives and Community Support
25/09/2024 - 16:19
Pages